Overview

Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or Midazolam

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of repeated-dose administration of itraconazole on the pharmacokinetics of TAK-272, as well as the effect of repeated-dose administration of TAK-272 on the pharmacokinetics of digoxin or midazolam in healthy Japanese adult males.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda
Treatments:
Digoxin
Hydroxyitraconazole
Imarikiren hydrochloride
Itraconazole
Midazolam